MetaCap

Arcus Biosciences Statistics

NYSE: RCUSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

15.62-0.16 (-1.01%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Arcus Biosciences by the numbers

Arcus Biosciences has a market capitalization of $2.25 billion based on 143.99M shares outstanding. With trailing EPS of $-3.64, Arcus Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 27.2% below its 50-day average and 35.8% below its 200-day average.

Average daily trading volume is 1.85M shares, or about $28.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

RCUS valuation vs. peer median

RCUS compared with the median of 8 peer companies
MetricRCUSPeer medianDifference
Market cap$2.25B$2.21B+2%
Avg. volume1.85M558.03K+232%

Peer median across 8 companies: HCM, PHVS, PRGO, NAMS, PBH, LKFT, PVLA, MBX.

Valuation

Price / sales (latest FY)
9.11
EPS (TTM)
$-3.64

Price and trading

Previous close
15.78
Open
15.66
Day range
15.56 – 16.66
52-week range
15.56 – 31.74
52-week change
-29.16%
Beta
—
Volume
1.67M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
2.25B
Forward Pe
-5.05
Eps
-3.64
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
31.74
Week52 Low
15.56
Avg Volume
1.85M
Shares Outstanding
143.99M
Ma50
21.47
Ma200
24.34
Earnings Date
Nov 4, 2026
Pct From52w High
-50.78%
Pct From52w Low
0.39%

Related